Asfar Azmi,
Assistant Professor,
Wayne State University School of Medicine
Dr. Asfar Azmi is an Assistant Professor in the Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan USA. He has more than a decade of experience in the area of small molecule drug development against important cancer targets such as Bcl-2, Mcl-1, nuclear exporter protein CRM1 and p21 activated kinase 4 (PAK4). Dr. Azmi’s work has led to the clinical translation of a number of cancer drugs such as CRM1 inhibitor Selinexor and recently the PAK4 inhibitor KPT-9274. He has published >100 peer reviewed articles and numerous thematic volumes in the area of cancer drug discovery. He is the author of multiple cancer drug discovery books and is also the Editor in Chief of the journal Oncobiology and Targets. He has received numerous young investigator awards from premier scientific bodies such as American Association for Cancer Research and American Pancreatic Association. His lab is well funded by the National Cancer Institute, National Institute of Health and by the pharmaceutical industry.
|
|
|